Oxford Biomedica PLC — Investor Relations & Filings
Oxford Biomedica (OXB) is a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. A pioneer in the field, the company has extensive experience in viral vectors, the enabling technology for many advanced therapies. OXB provides end-to-end services to pharmaceutical and biotechnology partners, supporting programs from preclinical development through to commercial launch. Its core expertise includes the development and GMP manufacturing of various vector types, including lentivirus, adeno-associated virus (AAV), and adenovirus. The company offers proprietary technologies like its LentiVector™ platform, the first commercially approved lentiviral system, and its inAAVate™ platform for AAV, in addition to tech-transfer capabilities.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director Declaration | 2026-05-27 | English | |
| Director/PDMR Shareholding | 2026-05-22 | English | |
| PDMR Dealing | 2026-05-19 | English | |
| PDMR Dealing | 2026-05-13 | English | |
| Print of AGM Resolutions | 2026-05-11 | English | |
| AGM Minutes | 2026-05-07 | English |
Browse filings by year
31 years- 2026 39 filings
- 2025 61 filings
- 2024 65 filings
- 2023 53 filings
- 2022 79 filings
- 2021 57 filings
- 2020 82 filings
- 2019 71 filings
- 2018 71 filings
- 2017 75 filings
- 2016 84 filings
- 2015 56 filings
- 2014 52 filings
- 2013 43 filings
- 2012 3 filings
- 2011 3 filings
- 2010 3 filings
- 2009 1 filing
- 2008 1 filing
- 2007 1 filing
- 2006 1 filing
- 2005 1 filing
- 2004 1 filing
- 2003 1 filing
- 2002 1 filing
- 2001 1 filing
- 2000 1 filing
- 1999 1 filing
- 1998 1 filing
- 1997 1 filing
- 1996 3 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47225895 | Director Declaration | 2026-05-27 | English | ||
| 46830411 | Director/PDMR Shareholding | 2026-05-22 | English | ||
| 46530409 | PDMR Dealing | 2026-05-19 | English | ||
| 45541627 | PDMR Dealing | 2026-05-13 | English | ||
| 44914653 | Print of AGM Resolutions | 2026-05-11 | English | ||
| 43633533 | AGM Minutes | 2026-05-07 | English | ||
| 43197184 | Result of AGM | 2026-05-07 | English | ||
| 39399113 | Total Voting Rights | 2026-05-01 | English | ||
| 39034920 | Admission to Trading | 2026-04-30 | English | ||
| 37376856 | Admission to Trading Application | 2026-04-27 | English | ||
| 34392469 | Launch of viral vector fast-track offering | 2026-04-13 | English | ||
| 33897356 | Grant of Awards | 2026-04-08 | English | ||
| 33128279 | Total Voting Rights | 2026-04-01 | English | ||
| 33090029 | Annual financial and audit reports | 2026-03-30 | English | ||
| 33090024 | Annual financial and audit reports | 2026-03-30 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Oxford Biomedica PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Humanwell Healthcare (Group) Co.,Ltd.
Global pharmaceutical firm specializing in CNS drugs, anest…
|
600079 | CN | Manufacturing |
|
HUMASIS CO., LTD.
Manufactures in-vitro diagnostic (IVD) devices for Point-of…
|
205470 | KR | Manufacturing |
|
Humedix Co., Ltd.
Develops and manufactures hyaluronic acid-based medical dev…
|
200670 | KR | Manufacturing |
|
HUNAN ER-KANG PHARMACEUTICAL CO.,LTD.
Manufactures pharmaceutical excipients, APIs, and plant-bas…
|
300267 | CN | Manufacturing |
|
HUNAN FANGSHENG PHARMACEUTICAL CO.,LTD
Researches and manufactures TCM, chemical drugs, and supple…
|
603998 | CN | Manufacturing |
|
Hunan Hansen Pharmaceutical Co.,Ltd.
Produces chemical drugs and TCM for cardiovascular, digesti…
|
002412 | CN | Manufacturing |
|
Hunan Jingfeng Pharmaceutical Co.,Ltd.
Researches and produces cardiovascular, cerebrovascular, or…
|
000908 | CN | Manufacturing |
|
Hunan Jiudian Pharmaceutical Co.,Ltd
Develops APIs and finished dosage forms, specializing in tr…
|
300705 | CN | Manufacturing |
|
Hunan Nucien Pharmaceutical Co., Ltd.
Develops and manufactures chemical drugs and APIs for diver…
|
688189 | CN | Manufacturing |
|
Hunan Warrant Pharmaceutical Co., Ltd.
Develops chemical APIs and high-end generics specializing i…
|
688799 | CN | Manufacturing |
Oxford Biomedica PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/5190/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=5190 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=5190 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=5190 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 5190}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Oxford Biomedica PLC (id: 5190)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.